Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alx Oncology Holdings Inc (NQ: ALXO ) 2.390 +0.060 (+2.58%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Alx Oncology Holdings Inc < Previous 1 2 3 4 5 Next > ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q2 2024 August 09, 2024 ALXO stock results show that ALX Oncology Holdings beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update August 08, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors August 06, 2024 From ALX Oncology Via GlobeNewswire Crude Oil Moves Lower; Moderna Shares Plunge August 01, 2024 Via Benzinga Exposures Fossil Fuels ALX Oncology Holdings Inc. (NASDAQ: ALXO) Leading the Way in Friday Trading Based on Percentage Gain December 08, 2023 Via Investor Brand Network Dow Dips Over 500 Points; ISM Manufacturing PMI Falls In July August 01, 2024 Via Benzinga Topics Stocks Exposures US Equities Nasdaq Surges 1%; Meta Posts Upbeat Earnings August 01, 2024 Via Benzinga Immuno-Oncology Focused ALX Oncology Stock Falls On Updated Data From Mid-Stage Evorpacept Combo Study In Gastric Cancer Patients August 01, 2024 ALX Oncology announces Phase 2 ASPEN-06 trial results for evorpacept in combination with trastuzumab, Cyramza, and paclitaxel for HER2-positive gastric/GEJ cancer. The trial shows significant... Via Benzinga Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket August 01, 2024 Via Benzinga ALX Oncology Reports Topline Data From ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Improves Tumor Response in Patients With HER2-Positive Gastric Cancer July 31, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology to Host Investor Call and Webcast to Share Topline Data Results From ASPEN-06 Phase 2 Clinical Trial of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer July 31, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer June 02, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference May 29, 2024 From ALX Oncology Via GlobeNewswire ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q1 2024 May 09, 2024 ALXO stock results show that ALX Oncology Holdings beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Appoints Allison Dillon as Chief Business Officer May 07, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer April 30, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting April 24, 2024 From ALX Oncology Via GlobeNewswire United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday April 17, 2024 U.S. stocks were lower, with the Dow Jones index falling over 50 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 17, 2024 Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings. Via Benzinga ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”) April 09, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer March 08, 2024 ALX Oncology's evorpacept, poised for pivotal HER2+ gastric cancer development. Caution prevails due to sub-$100 million market size; await additional plans backed by phase 1/2 data. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session March 08, 2024 Via Benzinga ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q4 2023 March 07, 2024 ALXO stock results show that ALX Oncology Holdings beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update March 07, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annual Meeting March 05, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From ALX Oncology Via GlobeNewswire 7 Small-Cap Stocks That Wall Street Loves for Good Reason December 22, 2023 The market rally is showing signs of broadening to include small-cap stocks, here are seven that analysts are upgrading Via InvestorPlace Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday December 22, 2023 U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sharply during Friday’s session following acquisition... Via Benzinga Topics Stocks Exposures US Equities Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 22, 2023 Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.